Another approach uses viruses that target cancer cell markers, such as CD46; tumors frequently express this molecule to evade complement-mediated immunity, allowing the measles virus (Edmonston strain) to infect cells via CD46 and selectively kill cancer cells with high receptor expression [83]. The gene discussed is CD46; the disease is cancer.